Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Creatine is an amino acid derivative naturally found in vertebrate tissues, primarily in muscle and brain. It plays a key role in cellular energy metabolism by facilitating the recycling of adenosine triphosphate (ATP) through the phosphocreatine system. In muscle tissue, creatine is stored as phosphocreatine, which rapidly donates phosphate groups to regenerate ATP during high-intensity, short-duration activities. Creatine supplementation increases intramuscular stores of phosphocreatine, enhancing performance and muscle mass during such exercises[1][6][8]. It is also used as a dietary supplement for potential benefits in certain neuromuscular and neurodegenerative conditions (e.g., muscular dystrophy, heart failure, Parkinson's disease), though its efficacy for these indications varies and it is not FDA-approved for any medical condition[3]. Creatine can be synthesized endogenously from amino acids or obtained from dietary sources like red meat and seafood; vegetarians may have lower baseline levels[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on creatine.